Role of detection of lipoarabinomannan (LAM) in urine for diagnosis of pulmonary tuberculosis in HIV patients; Egyptian experience

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202106822651688

Enrollment

214

Registered

2021-06-29

Start date

2015-01-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

laboratory test

laboratory

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study included seropositive HIV patients with a new diagnosis of either pulmonary or extra-pulmonary TB, and also included patients who were presented by symptoms suggestive for tuberculosis, changes in chest X ray that not improved by full course of antibiotics or positive tuberculin test = 5 mm.

Exclusion criteria

Exclusion criteria: Patients on anti-TB drugs or negative screening for sero-positive HIV patients were excluded from the study.

Design outcomes

Primary

Measure	Time frame
tb diagnosis	—

Secondary

Measure	Time frame
final diagnosis	—

Countries

Egypt

Contacts

Public ContactNessrin Shalaby

professor

nesrien@mans.edu.eg00201227931334

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026